1. Home
  2. PACB vs IIIV Comparison

PACB vs IIIV Comparison

Compare PACB & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • IIIV
  • Stock Information
  • Founded
  • PACB 2000
  • IIIV 2012
  • Country
  • PACB United States
  • IIIV United States
  • Employees
  • PACB N/A
  • IIIV N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • IIIV EDP Services
  • Sector
  • PACB Industrials
  • IIIV Technology
  • Exchange
  • PACB Nasdaq
  • IIIV Nasdaq
  • Market Cap
  • PACB 452.1M
  • IIIV 537.1M
  • IPO Year
  • PACB 2010
  • IIIV 2018
  • Fundamental
  • Price
  • PACB $2.42
  • IIIV $25.24
  • Analyst Decision
  • PACB Buy
  • IIIV Buy
  • Analyst Count
  • PACB 15
  • IIIV 7
  • Target Price
  • PACB $3.79
  • IIIV $27.14
  • AVG Volume (30 Days)
  • PACB 9.3M
  • IIIV 150.6K
  • Earning Date
  • PACB 11-07-2024
  • IIIV 11-13-2024
  • Dividend Yield
  • PACB N/A
  • IIIV N/A
  • EPS Growth
  • PACB N/A
  • IIIV N/A
  • EPS
  • PACB N/A
  • IIIV N/A
  • Revenue
  • PACB $188,871,000.00
  • IIIV $371,160,000.00
  • Revenue This Year
  • PACB N/A
  • IIIV N/A
  • Revenue Next Year
  • PACB $27.48
  • IIIV $1.85
  • P/E Ratio
  • PACB N/A
  • IIIV N/A
  • Revenue Growth
  • PACB 29.24
  • IIIV 46.48
  • 52 Week Low
  • PACB $1.16
  • IIIV $17.54
  • 52 Week High
  • PACB $10.65
  • IIIV $25.54
  • Technical
  • Relative Strength Index (RSI)
  • PACB 73.20
  • IIIV 73.65
  • Support Level
  • PACB $2.38
  • IIIV $22.89
  • Resistance Level
  • PACB $2.40
  • IIIV $25.54
  • Average True Range (ATR)
  • PACB 0.20
  • IIIV 0.46
  • MACD
  • PACB 0.07
  • IIIV 0.18
  • Stochastic Oscillator
  • PACB 89.31
  • IIIV 82.25

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About IIIV i3 Verticals Inc.

i3 Verticals Inc offers integrated payment and software solutions to small and medium-sized businesses and organizations in strategic vertical markets. Its operating segment includes Merchant Services and Software and Services. The company generates maximum revenue from the Software and Services segment. The company's strategic vertical market includes schools, the public sector, not-for-profit organizations, healthcare and others. It provides various solutions such as, gateway, payment processing, online payment, Document management, and ERP among others.

Share on Social Networks: